DENOSUMAB VERSUS RISEDRONATE: EFFICACY AND SAFETY IN POSTMENOPAUSAL WOMEN SUBOPTIMALLY ADHERENT TO ALENDRONATE THERAPY IN A RANDOMIZED OPEN-LABEL STUDY

C Roux; Astrid Fahrleitner-Pammer; PR Ho; F Hawkins; LC Hofbauer; M Micaelo; S Minisola; N Papaioannou; M Stone; J Wark; MC Zillikens; I Ferreira; S Siddhanti; RB Wagman; JP Brown

DENOSUMAB VERSUS RISEDRONATE: EFFICACY AND SAFETY IN POSTMENOPAUSAL WOMEN SUBOPTIMALLY ADHERENT TO ALENDRONATE THERAPY IN A RANDOMIZED OPEN-LABEL STUDY

C Roux
, Astrid Fahrleitner-Pammer
, PR Ho
, F Hawkins
, LC Hofbauer
, M Micaelo
, S Minisola
, N Papaioannou
, M Stone
, J Wark
, MC Zillikens
, I Ferreira
, S Siddhanti
, RB Wagman
, JP Brown

Klinische Abteilung für Endokrinologie und Diabetologie

Publikation: Beitrag in Fachzeitschrift › Konferenzabstract

1 Quellenangabe (Web of Science)

Originalsprache	Englisch
Fachzeitschrift	Annals of the Rheumatic Diseases
Publikationsstatus	Veröffentlicht - 2013
Veranstaltung	35th Annual Meeting of the American Society for Bone and Mineral Research - Baltimore, USA/Vereinigte Staaten Dauer: 4 Okt. 2013 → 7 Okt. 2013

Wissenschaftszweige

302 Klinische Medizin

Andere Dateien und Links

Web of Science

DENOSUMAB VERSUS RISEDRONATE: EFFICACY AND SAFETY IN POSTMENOPAUSAL WOMEN SUBOPTIMALLY ADHERENT TO ALENDRONATE THERAPY IN A RANDOMIZED OPEN-LABEL STUDY
Roux, C. (Autor*in), Fahrleitner-Pammer, A. (Autor*in), Ho, P. (Autor*in), Hawkins, F. (Autor*in), Hofbauer, L. (Autor*in), Micaelo, M. (Autor*in), Minisola, S. (Autor*in), Papaioannou, N. (Autor*in), Stone, M. (Autor*in), Wark, J. (Autor*in), Zillikens, M. (Autor*in), Ferreira, I. (Autor*in), Siddhanti, S. (Autor*in), Wagman, R. (Autor*in) & Brown, J. (Autor*in)
2013
Aktivität: Vortrag oder Poster › Wissenschaftliche Vortrag oder Präsentation › vor Ort

Dieses zitieren

Roux, C., Fahrleitner-Pammer, A., Ho, PR., Hawkins, F., Hofbauer, LC., Micaelo, M., Minisola, S., Papaioannou, N., Stone, M., Wark, J., Zillikens, MC., Ferreira, I., Siddhanti, S., Wagman, RB., & Brown, JP. (2013). DENOSUMAB VERSUS RISEDRONATE: EFFICACY AND SAFETY IN POSTMENOPAUSAL WOMEN SUBOPTIMALLY ADHERENT TO ALENDRONATE THERAPY IN A RANDOMIZED OPEN-LABEL STUDY. Annals of the Rheumatic Diseases.

@article{5f2ce499c7f84962ab856e355440e6b1,

title = "DENOSUMAB VERSUS RISEDRONATE: EFFICACY AND SAFETY IN POSTMENOPAUSAL WOMEN SUBOPTIMALLY ADHERENT TO ALENDRONATE THERAPY IN A RANDOMIZED OPEN-LABEL STUDY",

author = "C Roux and Astrid Fahrleitner-Pammer and PR Ho and F Hawkins and LC Hofbauer and M Micaelo and S Minisola and N Papaioannou and M Stone and J Wark and MC Zillikens and I Ferreira and S Siddhanti and RB Wagman and JP Brown",

year = "2013",

language = "English",

journal = "Annals of the Rheumatic Diseases",

issn = "0003-4967",

publisher = "Elsevier B.V.",

note = "35th Annual Meeting of the American Society for Bone and Mineral Research, ASMBR 35 ; Conference date: 04-10-2013 Through 07-10-2013",

}

Roux, C, Fahrleitner-Pammer, A, Ho, PR, Hawkins, F, Hofbauer, LC, Micaelo, M, Minisola, S, Papaioannou, N, Stone, M, Wark, J, Zillikens, MC, Ferreira, I, Siddhanti, S, Wagman, RB & Brown, JP 2013, 'DENOSUMAB VERSUS RISEDRONATE: EFFICACY AND SAFETY IN POSTMENOPAUSAL WOMEN SUBOPTIMALLY ADHERENT TO ALENDRONATE THERAPY IN A RANDOMIZED OPEN-LABEL STUDY', Annals of the Rheumatic Diseases.

TY - JOUR

T1 - DENOSUMAB VERSUS RISEDRONATE: EFFICACY AND SAFETY IN POSTMENOPAUSAL WOMEN SUBOPTIMALLY ADHERENT TO ALENDRONATE THERAPY IN A RANDOMIZED OPEN-LABEL STUDY

AU - Roux, C

AU - Fahrleitner-Pammer, Astrid

AU - Ho, PR

AU - Hawkins, F

AU - Hofbauer, LC

AU - Micaelo, M

AU - Minisola, S

AU - Papaioannou, N

AU - Stone, M

AU - Wark, J

AU - Zillikens, MC

AU - Ferreira, I

AU - Siddhanti, S

AU - Wagman, RB

AU - Brown, JP

PY - 2013

Y1 - 2013

UR - https://www.webofscience.com/wos/woscc/full-record/WOS:000331587902337

M3 - Conference abstract

SN - 0003-4967

JO - Annals of the Rheumatic Diseases

JF - Annals of the Rheumatic Diseases

T2 - 35th Annual Meeting of the American Society for Bone and Mineral Research

Y2 - 4 October 2013 through 7 October 2013

ER -

DENOSUMAB VERSUS RISEDRONATE: EFFICACY AND SAFETY IN POSTMENOPAUSAL WOMEN SUBOPTIMALLY ADHERENT TO ALENDRONATE THERAPY IN A RANDOMIZED OPEN-LABEL STUDY

Wissenschaftszweige

Andere Dateien und Links

Aktivitäten

DENOSUMAB VERSUS RISEDRONATE: EFFICACY AND SAFETY IN POSTMENOPAUSAL WOMEN SUBOPTIMALLY ADHERENT TO ALENDRONATE THERAPY IN A RANDOMIZED OPEN-LABEL STUDY

Dieses zitieren